Philip E. LeBoit, M.D.
- Phone: 415-353-7550
Peer Reviewed Publications:
Gerami P, Scolyer RA, Xu X, Elder DE, Abraham RM, Fullen D, Prieto VG, LeBoit PE, Barnhill RL, Cooper C, Yazdan P, Guitart J, Liu P, Pestova E, Busam K. Risk Assessment for Atypical Spitzoid Melanocytic Neoplasms Using FISH to Identify Chromosomal Copy Number Aberrations. Am J Surg Pathol. 2013 Feb 5 (Epub ahead of print) PubMed PMID: 23388126
Posch C, Moslehi H, Feeney L, Green GA, Ebaee A, Feichtenschlager V, Chong K, Peng L, Dimon MT, Phillips T, Daud AI, McCalmont TH, LeBoit PE, Ortiz-Urda S. Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo. Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):4015-20.
Wood BA, LeBoit PE. An 'inflammatory' variant of solar purpura: a simulant of leukocytoclastic vasculitis and neutrophilic dermatoses. Pathology. 2013 Aug;45(5):484-8
Charli-Joseph Y, Chong K, Ai WZ, LeBoit PE, ncus LB. Paneoplastic acanthosis nigricans paralleling disease course in a patient with mycosis fungoides. In press, Eur J Dermatol
Botton T, Yeh I, Nelson T, Vemula S, Sparatta A, Garrido M, Allegra M, Stephane Rocchi S, Bahadoran P, McCalmont TH, LeBoit PE, BurtonE, Bollag G, Ballotti R, Bastian B. Recurrent BRAF kinase fusions in melanocytic tumors offer an opportunity for targeted therapy. Submitted to Cancer Discovery.
Yang SH, Leboit PE. Angiomatous Kaposi Sarcoma: A Variant That Mimics/> Hemangiomas. Am J Dermatopathol. 2013 Sep 24. [Epub ahead of print] PubMed PMID:/> 24067801.
Kollipara R, Cooley L, Horii KA, Hetherington ML, Leboit PE, Singh V, Zwick D./> Spitzoid melanoma arising as a second malignancy in a child with Li-Fraumeni/> syndrome. Pediatr Dev Pathol. 2013 Nov 19. [Epub ahead of print] PubMed PMID:
- Massi G. LeBoit PE. Histological Diagnosis of Nevi and Melanoma. 2nd editon, Springer, Heidelberg, 2014
- Professor of Pathology and Dermatology
- Co-Director, UCSF Dermatopathology Service
After training in Anatomic Pathology at the University of California, San Francisco and in Dermatopathology at both New York University (under the late Bernard Ackerman, M.D.) and at New York Hospital-Cornell Medical Center (with N. Scott McNutt, M.D.),
I founded the UCSF Dermatopathology Service in 1987, with the goal of bringing academic expertise to a larger patient base than that of traditional university-based dermatopathology sections.
My investigative work includes the delineation of granulomatous slack skin as a lymphoma, the first comprehensive description of bacillary angiomatosis and bacillary peliosis hepatis, the development of the concept of palisaded neutrophilic and granulomatous dermatitis, the application of first morphometric and then molecular studies to melanocytic neoplasms and the initial description of nephrogenic systemic fibrosis.
I have written over 130 peer reviewed publications, over 25 book chapters, and co-edited the dermatology textbook, Cutaneous Medicine and Surgery. Another major project for the World Health Organization was editing the WHO "blue book" Skin Tumors. Guido Massi and I authored the textbook, Histologic Diagnosis of Nevi and Melanoma. I have given over 300 invited lectures in North and South America, Europe and Asia.
I served as editor-in-chief of the American Journal of Dermatopathology from 1997-2006, and am currently an editor of Seminars in Cutaneous Medicine and Surgery and an associate editor of the Journal of Investigative Dermatology. My service to the International Society of Dermatopathology includes membership on the executive committee and a term as Secretary-Treasurer. Currently, I am president of the Society. I have received the Ackerman Award from the International Society of Dermatopathology, and am the only person who has received both the Founders Award and the Pinkus Award from the American Society of Dermatopathology.